---
title: "Almaden Minerals grants director options for 800,000 shares at $0.27 each"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295923866.md"
description: "Almaden Minerals granted a director options for 800,000 common shares at an exercise price of $0.27 each, expiring on August 13, 2031. Additionally, the company renewed its shareholder rights plan following support from shareholders at the annual general and special meeting held on June 25, 2026."
datetime: "2026-08-14T11:01:17.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295923866.md)
  - [en](https://longbridge.com/en/news/295923866.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295923866.md)
generator: "portal-rs"
---

# Almaden Minerals grants director options for 800,000 shares at $0.27 each

-   Almaden renewed its shareholder rights plan following shareholder support at the June 25, 2026 annual general and special meeting. \* Stock options granted to a director for 800,000 common shares at an exercise price of $0.27, expiring Aug. 13, 2031. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Almaden Minerals Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608140700PRIMZONECNPR\_\_\_\_9810123) on August 14, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [AAUAF.US](https://longbridge.com/en/quote/AAUAF.US.md)

## Related News & Research

- [Almaden Minerals Files Unaudited Q2 2026 Interim Results with SEC](https://longbridge.com/en/news/295005386.md)
- [SoftwareOne attaches full H1 2026 report in correction to earlier release](https://longbridge.com/en/news/297010247.md)
- [Cemat publishes H1 2026 interim report](https://longbridge.com/en/news/297006906.md)
- [AgroGalaxy delays 2025 results release to Nov. 30, 2026](https://longbridge.com/en/news/297440664.md)
- [Corline Biomedical publishes January–June 2026 interim report](https://longbridge.com/en/news/296997165.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**